Table 5.
Mortality risk for plasminogen activator-1 plasma levels.*
| PAI-1 | ng/ml | Number of patients | Number of deaths | OR (95% CI) | ORadj (95% CI)° |
| Value at admission | <50 | 41 | 2 | 1 | 1 |
| 50–94 | 40 | 3 | 1.6 (0.3–10.0) | 3.3 (0.4–25.0) | |
| >94 | 41 | 8 | 4.7 (0.9–23.8) | 7.6 (1.2–49.3) | |
| Maximum value during admission | <72 | 41 | 2 | 1 | 1 |
| 72–151 | 42 | 3 | 1.5 (0.2–9.5) | 2.1 (0.2–18.2) | |
| >151 | 41 | 10 | 6.3 (1.3–30.8) | 7.4 (1.3–42.3) |
* CI, denotes confidence interval; OR, denotes odds ratio; ORadj, denotes adjusted odds ratio
° Risk of death adjusted for age, sex, year project and plasminogen activator inhhibitor-1 polymorphism. Lowest tertile was used as reference category.